Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Nanoviricides, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 29 | 27 | −2 |
| Shares | 1.11M | 1.17M | +59.3K (+5.3%) |
| Value | $4.13M | $2.45M | −$1.68M (−40.7%) |
New holders (3)
Institutions that held Nanoviricides, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 3,949 | $8.00K | 0.00% |
| Prospera Financial Services Inc | 450 | $1.00K | 0.00% |
| Glassman Wealth Services | 1 | $0 | 0.00% |
Sold out (5)
Institutions that held Nanoviricides, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Dimensional Fund Advisors LP | 29,154 | $108.0K |
| Harvest Investment Services, LLC | 14,267 | $53.0K |
| Citadel Advisors LLC | 13,615 | $51.0K |
| Simplex Trading, LLC | 6,287 | $23.0K |
| Private Capital Group, LLC | 400 | $2.00K |